A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects
NCT02111252 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2015-07-27
Summary
This clinical trial is a phase 1/2 study of a single intramuscular injection of TAK-850 in healthy Japanese adult participants
Conditions
Interventions
- DRUG
-
TAK-850
TAK-850 injection
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
General Manager · Takeda
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 49 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- Japan
More Related Trials
-
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
NCT00989612 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age
NCT06694389 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults
NCT02350751 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects
NCT03370289 ·Status: COMPLETED ·Phase: PHASE4
-
BPL-1357 Against H1N1 Influenza Virus Challenge
NCT07215858 ·Status: RECRUITING ·Phase: PHASE2
-
Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older
NCT01114620 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3
-
H7N9 Boost in Healthy Adults
NCT02586792 ·Status: COMPLETED ·Phase: PHASE2
-
Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX
NCT03232567 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958
NCT00995826 ·Status: COMPLETED ·Phase: PHASE1
-
H5N1 Vaccine Study in Japanese Adults
NCT01382329 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
NCT07121192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers
NCT02955030 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
NCT06097273 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
NCT01052480 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects
NCT01357265 ·Status: COMPLETED ·Phase: PHASE2
-
Intramuscular CodaVax-H1N1 in Healthy Adults
NCT05223179 ·Status: COMPLETED ·Phase: PHASE1
-
Universal Influenza A Vaccine in Healthy Adults
NCT05155319 ·Status: COMPLETED ·Phase: PHASE1
-
Blood and Plasma Collection For Use in Future Clinical Trials
NCT01136057 ·Status: COMPLETED
-
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
NCT01289535 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Intramuscular ASP7374
NCT01961960 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.
NCT02101749 ·Status: COMPLETED ·Phase: PHASE4
-
Self-Administered Nasal Influenza Feasibility Study
NCT01933048 ·Status: COMPLETED ·Phase: PHASE4